Prins, Renee C <br/><br/>
C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results.  [electronic resource] 

 -  Urologic oncology   
 - 33-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2496 
<br/><br/><label>Standard No.: </label>10.1016/j.urolonc.2009.11.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--analysis<br/>C-Reactive Protein--analysis<br/>Clinical Trials, Phase II as Topic<br/>Humans<br/>Inflammation--blood<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Proportional Hazards Models<br/>Prostatic Neoplasms--blood